Clinical Trials Directory

Trials / Terminated

TerminatedNCT02945527

Treatment of Peri-calcification Edema in Neurocysticercosis (NCC)

Open Controled Randomized Pilot Study on the Use of Acetazolamide and Dexamethasone for the Acute Phase of Perilesional Edema in Calcified Neurocysticercosis

Status
Terminated
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
4 (actual)
Sponsor
Universidad Peruana Cayetano Heredia · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Three-arm open, randomized comparative study of acetazolamide, dexamethasone, or no additional treatment to evaluate decrease in peri-calcification edema in neurocysticercosis

Detailed description

This study will evaluate 24 patients with calcified NCC and edema in three treatment arms to compare the reduction in edema volume

Conditions

Interventions

TypeNameDescription
DRUGAcetazolamideAs described above
DRUGDexamethasoneAs described above

Timeline

Start date
2015-12-04
Primary completion
2018-12-01
Completion
2018-12-01
First posted
2016-10-26
Last updated
2025-04-01

Locations

1 site across 1 country: Peru

Source: ClinicalTrials.gov record NCT02945527. Inclusion in this directory is not an endorsement.

Treatment of Peri-calcification Edema in Neurocysticercosis (NCC) (NCT02945527) · Clinical Trials Directory